Certara Launches Quantitative Systems Pharmacology Consortium on Immuno-oncology

Published on: 

Applied Clinical Trials

Certara announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. This new QSP brings together biopharmaceutical companies to create a simulator that can model clinical populations of cancer patients in order to improve the development of immuno-oncology therapies.

Read the full release here